AccuRna

Japan
Matsumaru, Ehime, Japan
+81-3-5803-2862 ★

Company profile

AccuRna company profile

AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.

Business identity

Contact email
[email protected]
Phone number
+81-3-5803-2862
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2015-12-01

Headquarters

Headquarters
Matsumaru, Ehime, Japan
Postal code
113-0033
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$7M
Last funding
Series B / $2.3M / 2019-12-23
Last equity funding
Series B / $2.3M
Investors
4
Lead investors
2
Exited on
2020-09-30

Founders and investors

Lead investors

Fast Track Initiative, Inc.UTokyo Innovation Platform

Investors

Fast Track Initiative, Inc.NanoCarrier CoSMBC Venture CapitalUTokyo Innovation Platform

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.